Oxford University

Accelerating drug development

All human clinical trials of new treatments begin with phase I, where drugs are tested in isolation to confirm their safety. Yet most effective cancer treatments use a combination of drugs, so-called 'multi-agent' ...

Mar 08, 2013
popularity 5 / 5 (3) | comments 0

Capturing cancer cells

(Medical Xpress)—When dealing with cancer, time is critical. Identifying cancer before it spreads can often be the difference between life and death, so early diagnosis is key.

Feb 26, 2013
popularity 5 / 5 (3) | comments 1 | with audio podcast

Runners benefit from new spin-out

Run3D Ltd, a new Oxford University spin-out company, provides a pioneering service to help runners avoid a common form of injury.

Dec 27, 2012
popularity not rated yet | comments 0